A R Mulick1, K E Mansfield1, R J Silverwood2,3, A Budu-Aggrey4, A Roberts5, A Custovic6, N Pearce1,3, A D Irvine7, L Smeeth1, K Abuabara8, S M Langan1,9. 1. Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. 2. Centre for Longitudinal Studies, Department of Social Science, University College London, London, UK. 3. Department of Medical Statistics, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. 4. MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. 5. Nottingham Support Group for Carers of Children with Eczema, Nottingham, UK. 6. National Heart & Lung Institute, Imperial College London, London, UK. 7. Clinical Medicine, Trinity College Dublin, Dublin 2, Ireland. 8. Department of Dermatology, University of California San Francisco, San Francisco, CA, USA. 9. Health Data Research UK, London, UK.
Abstract
BACKGROUND: Atopic dermatitis (AD) disease activity and severity is highly variable during childhood. Early attempts to identify subtypes based on disease trajectory have assessed AD presence over time without incorporating severity. OBJECTIVES: To identify childhood AD subtypes from symptom severity and trajectories, and determine associations with genetic risk factors, comorbidities and demographic and environmental variables. METHODS: We split data from children in the Avon Longitudinal Study of Parents and Children birth cohort into development and validation sets. To identify subtypes, we ran latent class analyses in the development set on AD symptom reports up to age 14 years. We regressed identified subtypes on nongenetic variables in mutually adjusted, multiply imputed (genetic: unadjusted, complete case) multinomial regression analyses. We repeated analyses in the validation set and report confirmed results. RESULTS: There were 11 866 children who contributed to analyses. We identified one Unaffected/Rare class (66% of children) and four AD subtypes: Severe-Frequent (4%), Moderate-Frequent (7%), Moderate-Declining (11%) and Mild-Intermittent (12%). Symptom patterns within the first two subtypes appeared more homogeneous than the last two. Filaggrin (FLG) null mutations, an AD polygenic risk score (PRS), being female, parental AD and comorbid asthma were associated with higher risk for some or all subtypes; FLG, AD-PRS and asthma associations were stronger along a subtype gradient arranged by increasing severity and frequency; FLG and AD-PRS further differentiated some phenotypes from each other. CONCLUSIONS: Considering severity and AD trajectories leads to four well-defined and recognizable subtypes. The differential associations of risk factors among and between subtypes is novel and requires further research.
BACKGROUND: Atopic dermatitis (AD) disease activity and severity is highly variable during childhood. Early attempts to identify subtypes based on disease trajectory have assessed AD presence over time without incorporating severity. OBJECTIVES: To identify childhood AD subtypes from symptom severity and trajectories, and determine associations with genetic risk factors, comorbidities and demographic and environmental variables. METHODS: We split data from children in the Avon Longitudinal Study of Parents and Children birth cohort into development and validation sets. To identify subtypes, we ran latent class analyses in the development set on AD symptom reports up to age 14 years. We regressed identified subtypes on nongenetic variables in mutually adjusted, multiply imputed (genetic: unadjusted, complete case) multinomial regression analyses. We repeated analyses in the validation set and report confirmed results. RESULTS: There were 11 866 children who contributed to analyses. We identified one Unaffected/Rare class (66% of children) and four AD subtypes: Severe-Frequent (4%), Moderate-Frequent (7%), Moderate-Declining (11%) and Mild-Intermittent (12%). Symptom patterns within the first two subtypes appeared more homogeneous than the last two. Filaggrin (FLG) null mutations, an AD polygenic risk score (PRS), being female, parental AD and comorbid asthma were associated with higher risk for some or all subtypes; FLG, AD-PRS and asthma associations were stronger along a subtype gradient arranged by increasing severity and frequency; FLG and AD-PRS further differentiated some phenotypes from each other. CONCLUSIONS: Considering severity and AD trajectories leads to four well-defined and recognizable subtypes. The differential associations of risk factors among and between subtypes is novel and requires further research.
Authors: Mark Boguniewicz; Luz Fonacier; Emma Guttman-Yassky; Peck Y Ong; Jonathan Silverberg; Judith Rosen Farrar Journal: Ann Allergy Asthma Immunol Date: 2018-01 Impact factor: 6.347
Authors: J I Silverberg; N Patel; S Immaneni; B Rusniak; N B Silverberg; R Debashis; N Fewkes; E L Simpson Journal: Br J Dermatol Date: 2015-10-23 Impact factor: 9.302
Authors: Danielle C M Belgrave; Raquel Granell; Angela Simpson; John Guiver; Christopher Bishop; Iain Buchan; A John Henderson; Adnan Custovic Journal: PLoS Med Date: 2014-10-21 Impact factor: 11.069
Authors: Lavinia Paternoster; Marie Standl; Johannes Waage; Hansjörg Baurecht; Melanie Hotze; David P Strachan; John A Curtin; Klaus Bønnelykke; Chao Tian; Atsushi Takahashi; Jorge Esparza-Gordillo; Alexessander Couto Alves; Jacob P Thyssen; Herman T den Dekker; Manuel A Ferreira; Elisabeth Altmaier; Patrick Ma Sleiman; Feng Li Xiao; Juan R Gonzalez; Ingo Marenholz; Birgit Kalb; Maria Pino Yanes; Cheng-Jian Xu; Lisbeth Carstensen; Maria M Groen-Blokhuis; Cristina Venturini; Craig E Pennell; Sheila J Barton; Albert M Levin; Ivan Curjuric; Mariona Bustamante; Eskil Kreiner-Møller; Gabrielle A Lockett; Jonas Bacelis; Supinda Bunyavanich; Rachel A Myers; Anja Matanovic; Ashish Kumar; Joyce Y Tung; Tomomitsu Hirota; Michiaki Kubo; Wendy L McArdle; A J Henderson; John P Kemp; Jie Zheng; George Davey Smith; Franz Rüschendorf; Anja Bauerfeind; Min Ae Lee-Kirsch; Andreas Arnold; Georg Homuth; Carsten O Schmidt; Elisabeth Mangold; Sven Cichon; Thomas Keil; Elke Rodríguez; Annette Peters; Andre Franke; Wolfgang Lieb; Natalija Novak; Regina Fölster-Holst; Momoko Horikoshi; Juha Pekkanen; Sylvain Sebert; Lise L Husemoen; Niels Grarup; Johan C de Jongste; Fernando Rivadeneira; Albert Hofman; Vincent Wv Jaddoe; Suzanne Gma Pasmans; Niels J Elbert; André G Uitterlinden; Guy B Marks; Philip J Thompson; Melanie C Matheson; Colin F Robertson; Janina S Ried; Jin Li; Xian Bo Zuo; Xiao Dong Zheng; Xian Yong Yin; Liang Dan Sun; Maeve A McAleer; Grainne M O'Regan; Caoimhe Mr Fahy; Linda E Campbell; Milan Macek; Michael Kurek; Donglei Hu; Celeste Eng; Dirkje S Postma; Bjarke Feenstra; Frank Geller; Jouke Jan Hottenga; Christel M Middeldorp; Pirro Hysi; Veronique Bataille; Tim Spector; Carla Mt Tiesler; Elisabeth Thiering; Badri Pahukasahasram; James J Yang; Medea Imboden; Scott Huntsman; Natàlia Vilor-Tejedor; Caroline L Relton; Ronny Myhre; Wenche Nystad; Adnan Custovic; Scott T Weiss; Deborah A Meyers; Cilla Söderhäll; Erik Melén; Carole Ober; Benjamin A Raby; Angela Simpson; Bo Jacobsson; John W Holloway; Hans Bisgaard; Jordi Sunyer; Nicole M Probst Hensch; L Keoki Williams; Keith M Godfrey; Carol A Wang; Dorret I Boomsma; Mads Melbye; Gerard H Koppelman; Deborah Jarvis; Wh Irwin McLean; Alan D Irvine; Xue Jun Zhang; Hakon Hakonarson; Christian Gieger; Esteban G Burchard; Nicholas G Martin; Liesbeth Duijts; Allan Linneberg; Marjo-Riitta Jarvelin; Markus M Noethen; Susanne Lau; Norbert Hübner; Young-Ae Lee; Mayumi Tamari; David A Hinds; Daniel Glass; Sara J Brown; Joachim Heinrich; David M Evans; Stephan Weidinger Journal: Nat Genet Date: 2015-10-19 Impact factor: 38.330
Authors: J Bousquet; J M Anto; M Wickman; T Keil; R Valenta; T Haahtela; K Lodrup Carlsen; M van Hage; C Akdis; C Bachert; M Akdis; C Auffray; I Annesi-Maesano; C Bindslev-Jensen; A Cambon-Thomsen; K H Carlsen; L Chatzi; F Forastiere; J Garcia-Aymerich; U Gehrig; S Guerra; J Heinrich; G H Koppelman; M L Kowalski; B Lambrecht; C Lupinek; D Maier; E Melén; I Momas; S Palkonen; M Pinart; D Postma; V Siroux; H A Smit; J Sunyer; J Wright; T Zuberbier; S H Arshad; R Nadif; C Thijs; N Andersson; A Asarnoj; N Ballardini; S Ballereau; A Bedbrook; M Benet; A Bergstrom; B Brunekreef; E Burte; M Calderon; G De Carlo; P Demoly; E Eller; M P Fantini; H Hammad; C Hohman; J Just; M Kerkhof; M Kogevinas; I Kull; S Lau; N Lemonnier; M Mommers; M Nawijn; A Neubauer; S Oddie; J Pellet; I Pin; D Porta; Y Saes; I Skrindo; C G Tischer; M Torrent; L von Hertzen Journal: Allergy Date: 2015-07-14 Impact factor: 13.146
Authors: Diego J Lopez; Caroline J Lodge; Dinh S Bui; Nilakshi T Waidyatillake; Michael J Abramson; Jennifer L Perret; John C Su; Bircan Erbas; Cecilie Svanes; Shyamali C Dharmage; Adrian J Lowe Journal: Clin Exp Allergy Date: 2022-04-04 Impact factor: 5.401